Evidence map›Paper›PMID 42193017›Full record

ArticleCancers2026

High Regnase-1 Expression Is Associated with an Immunosuppressive Tumor Microenvironment and Aggressive Features in Glioma Patients.

Kenza Miyara, Hamza Benthami, Hayat Miftah, Saadia Ait Ssi, Chaimae Boulhen, Abdelhakim Lakhdar, Abdallah Badou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kenza MiyaraImmuno-Genetics and Human Pathology Laboratory (LIGEP), Faculty of Medicine and Pharmacy, Hassan II University, Casablanca 20250, Morocco.
Hamza BenthamiImmuno-Genetics and Human Pathology Laboratory (LIGEP), Faculty of Medicine and Pharmacy, Hassan II University, Casablanca 20250, Morocco.
Hayat MiftahImmuno-Genetics and Human Pathology Laboratory (LIGEP), Faculty of Medicine and Pharmacy, Hassan II University, Casablanca 20250, Morocco.
Saadia Ait SsiImmuno-Genetics and Human Pathology Laboratory (LIGEP), Faculty of Medicine and Pharmacy, Hassan II University, Casablanca 20250, Morocco.
Chaimae BoulhenImmuno-Genetics and Human Pathology Laboratory (LIGEP), Faculty of Medicine and Pharmacy, Hassan II University, Casablanca 20250, Morocco.
Abdelhakim LakhdarDepartment of Neurosurgery, Ibn Rochd University Hospital Center (UHC), Casablanca 20360, Morocco.
Abdallah BadouImmuno-Genetics and Human Pathology Laboratory (LIGEP), Faculty of Medicine and Pharmacy, Hassan II University, Casablanca 20250, Morocco.ORCID 0000-0003-4849-9085

Funding

The Moroccan Ministry of Higher Education, Research and Innovation, the Moroccan Ministry of Industry, of Commerce, the Digital and Green Economy and the Digital Development Agency Alkhawarizmi/2020/08
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antitumor immune responseglioma prognosisimmune checkpoint regulationimmunosuppressionimmunotherapyRegnase-1tumor microenvironment

Identifiers

PMID42193017
PMCPMC13204960

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.